这是indexloc提供的服务,不要输入任何密码
Skip to main content
Account
Fig. 3 | Ophthalmology and Therapy

Fig. 3

From: Cost-Utility Analysis of Deep Learning and Trained Human Graders for Diabetic Retinopathy Screening in a Nationwide Program

Fig. 3

Total and disaggregated costs for the two screening strategies (HG and DL). The costs are for the cost-utility analysis at base case from both societal and provider perspectives. BB bilateral blindness, DL deep learning, DME diabetic macular edema, HG trained human graders, STDR sight-threatening diabetic retinopathy. Costs of treatment of DME and STDR without DME are presented separately. We assumed no direct medical costs for bilateral blindness; all the values are Thai baht in 2020

Back to article page